Compare · ACHC vs HUM
ACHC vs HUM
Side-by-side comparison of Acadia Healthcare Company Inc. (ACHC) and Humana Inc. (HUM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACHC and HUM operate in Medical Specialities (Health Care), so they compete in similar markets.
- HUM is the larger of the two at $39.42B, about 18.4x ACHC ($2.14B).
- HUM has been more active in the news (6 items in the past 4 weeks vs 5 for ACHC).
- Both have 25 recent analyst ratings on file.
- Company
- Acadia Healthcare Company Inc.
- Humana Inc.
- Price
- $23.31+0.30%
- $328.39+7.46%
- Market cap
- $2.14B
- $39.42B
- 1M return
- -9.97%
- -
- 1Y return
- +7.82%
- -
- Industry
- Medical Specialities
- Medical Specialities
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 5
- 6
- Recent ratings
- 25
- 25
Acadia Healthcare Company Inc.
Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States and Puerto Rico. The company operates acute inpatient psychiatric facilities, which cares to stabilize patients that are either threat to themselves or others by hourly observation, daily intervention, and monitoring by psychiatrists; and specialty treatment facilities, including residential recovery and eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders. It also provides residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs; and outpatient community-based services, such as community-based programs that are designed to offer therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorders. In addition, the company provides education and children's, and adult care services. As of March 31, 2021, it operated a network of 228 behavioral healthcare facilities with approximately 10,000 beds. The company was founded in 2005 and is headquartered in Franklin, Tennessee.
Humana Inc.
Humana Inc., together with its subsidiaries, operates as a health and well-being company in the United States. It operates through Retail, Group and Specialty, and Healthcare Services segments. The company offers medical and supplemental benefit plans to individuals. It also has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits. In addition, the company provides commercial fully-insured medical and specialty health insurance benefits comprising dental, vision, and other supplemental health benefits; and administrative services only products to individuals and employer groups, as well as military services, such as TRICARE T2017 East Region contract. Further, it offers pharmacy solutions, provider services, predictive modeling and informatics services, and clinical care services, such as home health and other services to its health plan members, as well as to third parties. As of December 31, 2020, the company had approximately 17 million members in medical benefit plans, as well as approximately 5 million members in specialty products. Humana Inc. was incorporated in 1964 and is headquartered in Louisville, Kentucky.
Latest ACHC
- SEC Form 8-K filed by Acadia Healthcare Company Inc.
- Amendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.
- SEC Form S-8 filed by Acadia Healthcare Company Inc.
- New insider Duckworth David M. claimed ownership of 750 shares (SEC Form 3)
- Amendment: SEC Form SCHEDULE 13G/A filed by Acadia Healthcare Company Inc.
- Director Fucci Michael was granted 6,331 shares, increasing direct ownership by 29% to 28,152 units (SEC Form 4)
- Director Waud Reeve B was granted 15,907 shares, increasing direct ownership by 27% to 75,859 units (SEC Form 4)
- Director Bernhard Jason was granted 11,455 shares, increasing direct ownership by 34% to 45,359 units (SEC Form 4)
- Director Harris Patrice A was granted 6,331 shares, increasing direct ownership by 55% to 17,914 units (SEC Form 4)
- Director Kelly Ralph David was granted 6,331 shares, increasing direct ownership by 32% to 26,358 units (SEC Form 4)
Latest HUM
- Humana Inc. filed SEC Form 8-K: Regulation FD Disclosure
- Humana completes $83 million Florida infrastructure investment to deepen coordinated patient care approach
- Humana upgraded by Deutsche Bank with a new price target
- Humana Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Humana, CenterWell and USAA Unite with VFW for National Day of Service Supporting Veterans Experiencing Homelessness
- Humana Invests More Than $1 Million to Advance Health Outcomes Across Louisiana
- Chief Financial Officer Mellet Celeste gave a grant of 15,387 units of Humana Common, decreasing direct ownership by 28% to 39,637 units (SEC Form 4)
- Chief Information Officer Mehta Japan was granted 9,448 units of Humana Common, increasing direct ownership by 122% to 17,176 units (SEC Form 4)
- President, Enterprise Growth Dintenfass David was granted 11,273 units of Humana Common, increasing direct ownership by 80% to 25,407 units (SEC Form 4)
- President & CEO Rechtin James A. was granted 35,633 units of Humana Common (SEC Form 4)